]>

Table 1: Five-year cancer-specific survival for node-positive disease following nephroureterectomy and lymph node dissection.

Number of node-positive patients Five-year cancer-specific survival Johansson and Wahlqvist [19] N/A 0% Secin et al. [15] 28 0% Miyake et al. [17] 13 0% Novara et al. [7] 27 12% Kondo et al. [14] 42 15% Park et al. [20] 11 27% Roscigno et al. [16] 26 39%